Symbol:
Nipbl
Name:
NIPBL, cohesin loading factor
RGD ID:
1306393
Description:
Predicted to enable several functions, including chromo shadow domain binding activity; cohesin loader activity; and histone deacetylase binding activity. Predicted to be involved in several processes, including chromosome organization; embryonic morphogenesis; and reproductive structure development. Predicted to act upstream of or within several processes, including embryonic cranial skeleton morphogenesis; fat cell differentiation; and positive regulation of ossification. Predicted to be located in chromatin; cytosol; and nucleoplasm. Predicted to be part of Scc2-Scc4 cohesin loading complex and integrator complex. Human ortholog(s) of this gene implicated in Cornelia de Lange syndrome and Cornelia de Lange syndrome 1. Orthologous to human NIPBL (NIPBL cohesin loading factor); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil; acrylamide.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
delangin; IDN3; Nipped-B homolog; Nipped-B homolog (Drosophila); nipped-B-like protein
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 59,126,676 - 59,314,841 (-) NCBI GRCr8 mRatBN7.2 2 57,399,443 - 57,586,770 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 57,399,445 - 57,565,899 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 2 57,508,830 - 57,676,197 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 57,509,428 - 57,600,820 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 78,992,721 - 79,160,884 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 57,908,828 - 58,099,422 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 57,837,538 - 58,006,254 (-) NCBI Celera 2 53,014,297 - 53,179,686 (-) NCBI Celera Cytogenetic Map 2 q16 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Nipbl Rat 1,2-dimethylhydrazine decreases expression ISO Nipbl (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of NIPBL mRNA CTD PMID:22206623 Nipbl Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nipbl (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NIPBL mRNA CTD PMID:21570461 Nipbl Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NIPBL mRNA CTD PMID:32109520 and PMID:34747641 Nipbl Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Nipbl (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of NIPBL mRNA CTD PMID:19465110 Nipbl Rat 2,4,6-tribromophenol increases expression ISO NIPBL (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Nipbl Rat 3,3',5,5'-tetrabromobisphenol A increases expression ISO NIPBL (Homo sapiens) 6480464 tetrabromobisphenol A results in increased expression of NIPBL protein CTD PMID:31675489 Nipbl Rat 4,4'-sulfonyldiphenol decreases expression ISO Nipbl (Mus musculus) 6480464 bisphenol S results in decreased expression of NIPBL mRNA CTD PMID:39298647 Nipbl Rat 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO NIPBL (Homo sapiens) 6480464 NIPBL mRNA alternative form promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of FEN1 protein] more ... CTD PMID:35435490 Nipbl Rat 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO NIPBL (Homo sapiens) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NIPBL mRNA alternative form CTD PMID:35435490 Nipbl Rat 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases response to substance ISO NIPBL (Homo sapiens) 6480464 NIPBL mRNA alternative form results in increased susceptibility to 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:35435490 Nipbl Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NIPBL mRNA CTD PMID:30047161 Nipbl Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of NIPBL mRNA CTD PMID:28959563 Nipbl Rat afimoxifene affects response to substance ISO NIPBL (Homo sapiens) 6480464 NIPBL gene affects the susceptibility to afimoxifene CTD PMID:21482774 Nipbl Rat aflatoxin B1 increases expression ISO Nipbl (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of NIPBL mRNA CTD PMID:19770486 Nipbl Rat all-trans-retinoic acid decreases expression ISO NIPBL (Homo sapiens) 6480464 Tretinoin results in decreased expression of NIPBL mRNA CTD PMID:21934132 Nipbl Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of NIPBL mRNA CTD PMID:30047161 Nipbl Rat antirheumatic drug decreases expression ISO NIPBL (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of NIPBL mRNA CTD PMID:24449571 Nipbl Rat aristolochic acid A decreases expression ISO NIPBL (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of NIPBL mRNA CTD PMID:33212167 Nipbl Rat Aroclor 1254 decreases expression ISO Nipbl (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NIPBL mRNA CTD PMID:23650126 Nipbl Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of NIPBL gene CTD PMID:28931070 Nipbl Rat benzo[a]pyrene increases methylation ISO Nipbl (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of NIPBL exon and Benzo(a)pyrene results in increased methylation of NIPBL intron CTD PMID:27901495 Nipbl Rat benzo[a]pyrene diol epoxide I decreases expression ISO NIPBL (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Nipbl Rat bis(2-ethylhexyl) phthalate decreases expression ISO Nipbl (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of NIPBL mRNA CTD PMID:33754040 Nipbl Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NIPBL mRNA CTD PMID:30816183 Nipbl Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NIPBL mRNA CTD PMID:32528016 Nipbl Rat Bisphenol A diglycidyl ether affects splicing ISO Nipbl (Mus musculus) 6480464 bisphenol A diglycidyl ether affects the splicing of NIPBL mRNA CTD PMID:36464114 Nipbl Rat bisphenol AF affects splicing ISO Nipbl (Mus musculus) 6480464 bisphenol AF affects the splicing of NIPBL mRNA CTD PMID:36464114 Nipbl Rat cadmium dichloride decreases expression ISO Nipbl (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of NIPBL mRNA CTD PMID:24982889 Nipbl Rat caffeine affects phosphorylation ISO NIPBL (Homo sapiens) 6480464 Caffeine affects the phosphorylation of NIPBL protein CTD PMID:35688186 Nipbl Rat choline multiple interactions ISO Nipbl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NIPBL gene CTD PMID:20938992 Nipbl Rat cisplatin decreases expression ISO NIPBL (Homo sapiens) 6480464 Cisplatin results in decreased expression of NIPBL mRNA CTD PMID:27392435 Nipbl Rat cisplatin multiple interactions ISO NIPBL (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of NIPBL mRNA CTD PMID:27392435 Nipbl Rat clorgyline increases expression ISO NIPBL (Homo sapiens) 6480464 Clorgyline results in increased expression of NIPBL mRNA CTD PMID:19691856 Nipbl Rat coumarin decreases phosphorylation ISO NIPBL (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of NIPBL protein CTD PMID:35688186 Nipbl Rat crocidolite asbestos decreases expression ISO Nipbl (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of NIPBL mRNA CTD PMID:29279043 Nipbl Rat cyclosporin A increases expression ISO Nipbl (Mus musculus) 6480464 Cyclosporine results in increased expression of NIPBL mRNA CTD PMID:19770486 Nipbl Rat decabromodiphenyl ether increases expression ISO NIPBL (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of NIPBL protein CTD PMID:31675489 Nipbl Rat deoxynivalenol increases phosphorylation ISO Nipbl (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of NIPBL protein CTD PMID:23811945 Nipbl Rat Dibutyl phosphate affects expression ISO NIPBL (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of NIPBL mRNA CTD PMID:37042841 Nipbl Rat dibutyl phthalate increases expression ISO Nipbl (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of NIPBL mRNA CTD PMID:21266533 Nipbl Rat dorsomorphin multiple interactions ISO NIPBL (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIPBL mRNA CTD PMID:27188386 Nipbl Rat elemental selenium decreases expression ISO NIPBL (Homo sapiens) 6480464 Selenium results in decreased expression of NIPBL mRNA CTD PMID:19244175 Nipbl Rat enzyme inhibitor multiple interactions ISO NIPBL (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NIPBL protein CTD PMID:23301498 Nipbl Rat epoxiconazole increases expression ISO Nipbl (Mus musculus) 6480464 epoxiconazole results in increased expression of NIPBL mRNA CTD PMID:35436446 Nipbl Rat fenthion decreases expression ISO Nipbl (Mus musculus) 6480464 Fenthion results in decreased expression of NIPBL mRNA CTD PMID:34813904 Nipbl Rat folic acid multiple interactions ISO Nipbl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NIPBL gene CTD PMID:20938992 Nipbl Rat FR900359 affects phosphorylation ISO NIPBL (Homo sapiens) 6480464 FR900359 affects the phosphorylation of NIPBL protein CTD PMID:37730182 Nipbl Rat gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of NIPBL mRNA CTD PMID:17785943 Nipbl Rat geldanamycin increases expression ISO NIPBL (Homo sapiens) 6480464 geldanamycin results in increased expression of NIPBL mRNA CTD PMID:26705709 Nipbl Rat genistein increases expression ISO NIPBL (Homo sapiens) 6480464 Genistein results in increased expression of NIPBL mRNA CTD PMID:19371625 Nipbl Rat gold atom multiple interactions ISO Nipbl (Mus musculus) 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of NIPBL mRNA CTD PMID:19695318 Nipbl Rat gold(0) multiple interactions ISO Nipbl (Mus musculus) 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of NIPBL mRNA CTD PMID:19695318 Nipbl Rat inulin multiple interactions ISO Nipbl (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NIPBL mRNA CTD PMID:36331819 Nipbl Rat L-methionine multiple interactions ISO Nipbl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NIPBL gene CTD PMID:20938992 Nipbl Rat leflunomide decreases expression ISO Nipbl (Mus musculus) 6480464 leflunomide results in decreased expression of NIPBL mRNA CTD PMID:19751817 Nipbl Rat maneb multiple interactions ISO Nipbl (Mus musculus) 6480464 [Paraquat co-treated with Maneb] affects the expression of NIPBL mRNA CTD PMID:22563483 Nipbl Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of NIPBL mRNA CTD PMID:30047161 Nipbl Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NIPBL mRNA CTD PMID:25729387 Nipbl Rat paraquat increases expression ISO Nipbl (Mus musculus) 6480464 Paraquat results in increased expression of NIPBL mRNA CTD PMID:22563483 Nipbl Rat paraquat multiple interactions ISO Nipbl (Mus musculus) 6480464 [Paraquat co-treated with Maneb] affects the expression of NIPBL mRNA CTD PMID:22563483 Nipbl Rat perfluorooctane-1-sulfonic acid decreases expression ISO NIPBL (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of NIPBL mRNA CTD PMID:27153767 Nipbl Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Nipbl (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NIPBL mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NIPBL mRNA CTD PMID:36331819 Nipbl Rat phenobarbital decreases expression ISO Nipbl (Mus musculus) 6480464 Phenobarbital results in decreased expression of NIPBL mRNA CTD PMID:19270015 and PMID:23091169 Nipbl Rat potassium dichromate decreases expression ISO Nipbl (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of NIPBL mRNA CTD PMID:23608068 Nipbl Rat propiconazole decreases expression ISO Nipbl (Mus musculus) 6480464 propiconazole results in decreased expression of NIPBL mRNA CTD PMID:21278054 Nipbl Rat pyridaben increases expression ISO Nipbl (Mus musculus) 6480464 pyridaben results in increased expression of NIPBL mRNA CTD PMID:22563483 Nipbl Rat quercetin affects phosphorylation ISO NIPBL (Homo sapiens) 6480464 Quercetin affects the phosphorylation of NIPBL protein CTD PMID:35688186 Nipbl Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of NIPBL mRNA CTD PMID:19013527 Nipbl Rat SB 431542 multiple interactions ISO NIPBL (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIPBL mRNA CTD PMID:27188386 Nipbl Rat selenium atom decreases expression ISO NIPBL (Homo sapiens) 6480464 Selenium results in decreased expression of NIPBL mRNA CTD PMID:19244175 Nipbl Rat sodium arsenate increases expression ISO Nipbl (Mus musculus) 6480464 sodium arsenate results in increased expression of NIPBL mRNA CTD PMID:21795629 Nipbl Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of NIPBL mRNA CTD PMID:30047161 Nipbl Rat thimerosal decreases expression ISO NIPBL (Homo sapiens) 6480464 Thimerosal results in decreased expression of NIPBL mRNA CTD PMID:27188386 Nipbl Rat thiram increases expression ISO NIPBL (Homo sapiens) 6480464 Thiram results in increased expression of NIPBL mRNA CTD PMID:38568856 Nipbl Rat titanium dioxide increases methylation ISO Nipbl (Mus musculus) 6480464 titanium dioxide results in increased methylation of NIPBL promoter CTD PMID:35295148 Nipbl Rat titanium dioxide decreases methylation ISO Nipbl (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NIPBL gene CTD PMID:35295148 Nipbl Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NIPBL mRNA CTD PMID:25729387 Nipbl Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of NIPBL mRNA CTD PMID:25729387 Nipbl Rat trichostatin A decreases expression ISO NIPBL (Homo sapiens) 6480464 trichostatin A results in decreased expression of NIPBL mRNA CTD PMID:24935251 and PMID:26272509 Nipbl Rat trichostatin A multiple interactions ISO NIPBL (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIPBL mRNA CTD PMID:27188386 Nipbl Rat triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of NIPBL mRNA CTD PMID:30589522 Nipbl Rat troglitazone decreases expression ISO Nipbl (Mus musculus) 6480464 troglitazone results in decreased expression of NIPBL mRNA CTD PMID:28973697 Nipbl Rat tungsten decreases expression ISO Nipbl (Mus musculus) 6480464 Tungsten results in decreased expression of NIPBL mRNA CTD PMID:30912803 Nipbl Rat urethane increases expression ISO NIPBL (Homo sapiens) 6480464 Urethane results in increased expression of NIPBL mRNA CTD PMID:28818685 Nipbl Rat valproic acid affects expression ISO NIPBL (Homo sapiens) 6480464 Valproic Acid affects the expression of NIPBL mRNA CTD PMID:25979313 Nipbl Rat valproic acid decreases expression ISO NIPBL (Homo sapiens) 6480464 Valproic Acid results in decreased expression of NIPBL mRNA CTD PMID:23179753 more ... Nipbl Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NIPBL mRNA CTD PMID:19015723 Nipbl Rat vitamin E decreases expression ISO NIPBL (Homo sapiens) 6480464 Vitamin E results in decreased expression of NIPBL mRNA CTD PMID:19244175 Nipbl Rat vorinostat decreases expression ISO NIPBL (Homo sapiens) 6480464 vorinostat results in decreased expression of NIPBL mRNA CTD PMID:27188386
1,2-dimethylhydrazine (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-tribromophenol (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 4,4'-sulfonyldiphenol (ISO) 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one (ISO) 6-propyl-2-thiouracil (EXP) acrylamide (EXP) afimoxifene (ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) amitrole (EXP) antirheumatic drug (ISO) aristolochic acid A (ISO) Aroclor 1254 (ISO) atrazine (EXP) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP) Bisphenol A diglycidyl ether (ISO) bisphenol AF (ISO) cadmium dichloride (ISO) caffeine (ISO) choline (ISO) cisplatin (ISO) clorgyline (ISO) coumarin (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) decabromodiphenyl ether (ISO) deoxynivalenol (ISO) Dibutyl phosphate (ISO) dibutyl phthalate (ISO) dorsomorphin (ISO) elemental selenium (ISO) enzyme inhibitor (ISO) epoxiconazole (ISO) fenthion (ISO) folic acid (ISO) FR900359 (ISO) gamma-hexachlorocyclohexane (EXP) geldanamycin (ISO) genistein (ISO) gold atom (ISO) gold(0) (ISO) inulin (ISO) L-methionine (ISO) leflunomide (ISO) maneb (ISO) methimazole (EXP) oxaliplatin (EXP) paraquat (ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) potassium dichromate (ISO) propiconazole (ISO) pyridaben (ISO) quercetin (ISO) rotenone (EXP) SB 431542 (ISO) selenium atom (ISO) sodium arsenate (ISO) sulfadimethoxine (EXP) thimerosal (ISO) thiram (ISO) titanium dioxide (ISO) topotecan (EXP) trichostatin A (ISO) triphenyl phosphate (EXP) troglitazone (ISO) tungsten (ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP) vitamin E (ISO) vorinostat (ISO)
Biological Process
biological_process (ND) brain development (IBA,IEA,ISO) cellular response to X-ray (IEA,ISO) chromatin looping (IEA) chromatin remodeling (IEA,ISO) cognition (IEA,ISO) developmental growth (IEA,ISO) digestive tract development (IBA) DNA damage response (IEA,ISO) ear morphogenesis (IEA,ISO) embryonic cranial skeleton morphogenesis (IEA,ISO) embryonic digestive tract morphogenesis (IEA,ISO) embryonic forelimb morphogenesis (IEA,ISO) embryonic viscerocranium morphogenesis (IBA,IEA,ISO) establishment of mitotic sister chromatid cohesion (IBA) establishment of protein localization to chromatin (IBA) external genitalia morphogenesis (IEA,ISO) eye morphogenesis (IEA,ISO) face morphogenesis (IEA,ISO) fat cell differentiation (IEA,ISO) forelimb morphogenesis (IEA,ISO) gallbladder development (IEA,ISO) heart development (IEA,ISO) heart morphogenesis (IBA,IEA,ISO) maintenance of mitotic sister chromatid cohesion (IEA,ISO) mitotic sister chromatid cohesion (IEA,ISO) mitotic sister chromatid segregation (IEA,ISO) negative regulation of transcription by RNA polymerase II (IEA,ISO) outflow tract morphogenesis (IEA,ISO) positive regulation of multicellular organism growth (IEA,ISO) positive regulation of neuron migration (IEA,ISO) positive regulation of ossification (IEA,ISO) positive regulation of transcription by RNA polymerase II (IEA,ISO) protein localization (IEA,ISO) regulation of developmental growth (IEA,ISO) regulation of embryonic development (IEA,ISO) regulation of gene expression (IEA) regulation of hair cycle (IEA,ISO) regulation of transcription by RNA polymerase II (IEA,ISO) replication-born double-strand break repair via sister chromatid exchange (IBA) sensory perception of sound (IEA,ISO) somatic stem cell population maintenance (IEA,ISO) uterus morphogenesis (IEA,ISO)
1.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
2.
NIPBL expression levels in CdLS probands as a predictor of mutation type and phenotypic severity.
Kaur M, etal., Am J Med Genet C Semin Med Genet. 2016 Jun;172(2):163-70. doi: 10.1002/ajmg.c.31495. Epub 2016 Apr 29.
3.
Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/-) mouse, a model of Cornelia de Lange Syndrome.
Kawauchi S, etal., PLoS Genet. 2009 Sep;5(9):e1000650. doi: 10.1371/journal.pgen.1000650. Epub 2009 Sep 18.
4.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
5.
Online Mendelian Inheritance in Man, OMIM (TM).
Online Mendelian Inheritance in Man, OMIM (TM).
6.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
7.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
8.
Comprehensive gene review and curation
RGD comprehensive gene curation
9.
Intragenic and large NIPBL rearrangements revealed by MLPA in Cornelia de Lange patients.
Russo S, etal., Eur J Hum Genet. 2012 Jul;20(7):734-41. doi: 10.1038/ejhg.2012.7. Epub 2012 Feb 22.
Nipbl Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 59,126,676 - 59,314,841 (-) NCBI GRCr8 mRatBN7.2 2 57,399,443 - 57,586,770 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 57,399,445 - 57,565,899 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 2 57,508,830 - 57,676,197 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 57,509,428 - 57,600,820 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 78,992,721 - 79,160,884 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 57,908,828 - 58,099,422 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 57,837,538 - 58,006,254 (-) NCBI Celera 2 53,014,297 - 53,179,686 (-) NCBI Celera Cytogenetic Map 2 q16 NCBI
NIPBL Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 5 36,876,769 - 37,066,413 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 5 36,876,769 - 37,066,413 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 5 36,876,871 - 37,066,515 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 5 36,912,742 - 37,101,678 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 5 36,763,790 - 36,952,889 (+) NCBI Celera Cytogenetic Map 5 p13.2 NCBI HuRef 5 36,829,492 - 37,018,602 (+) NCBI HuRef CHM1_1 5 36,879,597 - 37,068,738 (+) NCBI CHM1_1 T2T-CHM13v2.0 5 37,126,599 - 37,316,247 (+) NCBI T2T-CHM13v2.0
Nipbl Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 15 8,319,308 - 8,494,799 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 15 8,320,101 - 8,473,947 (-) Ensembl GRCm39 Ensembl GRCm38 15 8,289,824 - 8,465,315 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 15 8,290,617 - 8,444,463 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 15 8,241,225 - 8,394,463 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 15 8,238,440 - 8,391,678 (-) NCBI MGSCv36 mm8 Celera 15 8,136,258 - 8,289,610 (-) NCBI Celera Cytogenetic Map 15 A1 NCBI cM Map 15 3.82 NCBI
Nipbl Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955426 21,666,857 - 21,841,515 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955426 21,666,958 - 21,841,515 (+) NCBI ChiLan1.0 ChiLan1.0
NIPBL Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 4 73,270,202 - 73,457,542 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 5 71,423,834 - 71,611,174 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 5 73,306,527 - 73,491,367 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 5 78,585,649 - 78,772,665 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 5 78,585,649 - 78,698,184 (-) Ensembl panpan1.1 panPan2
NIPBL Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 4 71,583,118 - 71,780,986 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 4 71,583,732 - 71,780,852 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 4 71,193,245 - 71,390,556 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 4 72,093,046 - 72,290,807 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 4 72,093,358 - 72,290,830 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 4 71,840,270 - 72,037,537 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 4 71,962,190 - 72,159,916 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 4 72,493,866 - 72,691,524 (-) NCBI UU_Cfam_GSD_1.0
Nipbl Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024407213 226,330,734 - 226,501,147 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936518 4,869,546 - 4,969,450 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936518 4,870,686 - 5,041,099 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
NIPBL Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 16 22,152,469 - 22,363,821 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 16 22,152,455 - 22,364,373 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 16 23,393,877 - 23,512,467 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
NIPBL Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 4 35,748,112 - 35,940,075 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 4 35,829,386 - 35,941,271 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666071 26,085,896 - 26,277,759 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Nipbl
.
Predicted Target Of
Count of predictions: 36 Count of miRNA genes: 30 Interacting mature miRNAs: 34 Transcripts: ENSRNOT00000021181, ENSRNOT00000065395 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
6480225 Gdil1 Gastrointestinal dilation QTL 1 enteric ganglion morphology trait (VT:0001045) length of intestine affected by colonic aganglionosis to total length of colon ratio (CMO:0001836) 2 56660879 74786777 Rat 2293671 Bss44 Bone structure and strength QTL 44 10.97 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 2 43162366 148478373 Rat 7387318 Stl32 Serum triglyceride level QTL 32 3.2 0.0003 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 2 22384627 67384627 Rat 10755436 Coatc8 Coat color QTL 8 0.02431 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 2 35023117 80023117 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 10755434 Coatc7 Coat color QTL 7 0.04794 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 2 30648065 75648065 Rat 2293676 Bmd19 Bone mineral density QTL 19 10.7 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 2 43162366 111362592 Rat 10755499 Bp389 Blood pressure QTL 389 2.61 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 18960362 228801039 Rat 2293682 Bmd24 Bone mineral density QTL 24 8.9 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 2 43162366 111362592 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 731167 Glom4 Glomerulus QTL 4 2.4 0.0082 kidney glomerulus morphology trait (VT:0005325) count of superficial glomeruli not directly contacting the kidney surface (CMO:0001002) 2 20304672 65304672 Rat 1579916 Bp270 Blood pressure QTL 270 0.003 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56531912 59324719 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 152025242 Bw191 Body weight QTL 191 3.62 body mass (VT:0001259) 2 38573329 122609194 Rat 1302794 Stl27 Serum triglyceride level QTL 27 4.4 0.0001 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 2 25413423 143657569 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 43154682 202446871 Rat 10402051 Gdil2 Gastrointestinal dilation QTL 2 enteric ganglion morphology trait (VT:0001045) length of intestine affected by colonic aganglionosis to total length of colon ratio (CMO:0001836) 2 24903853 74786777 Rat 9590095 Sffal3 Serum free fatty acids level QTL 3 6.78 0.001 blood free fatty acid amount (VT:0001553) plasma free fatty acids level (CMO:0000546) 2 27157160 72157160 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 2 40067944 102785628 Rat 1358901 Cm38 Cardiac mass QTL 38 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 631208 Bw1 Body weight QTL1 5.09 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 2 43171017 83575226 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56043031 202447032 Rat 1358899 Kidm23 Kidney mass QTL 23 3.88 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358908 Bw49 Body weight QTL 49 3.36 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1300155 Bp174 Blood pressure QTL 174 4.09 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 2 42804607 60653831 Rat 2293835 Kiddil5 Kidney dilation QTL 5 3.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 157142209 Rat 1358910 Kidm27 Kidney mass QTL 27 5.77 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 61355 Bp36 Blood pressure QTL 36 2.9 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 2 5873687 102844969 Rat 2300168 Bmd47 Bone mineral density QTL 47 6.6 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 2 20662448 65662448 Rat 1358911 Kidm28 Kidney mass QTL 28 5.42 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 46123260 202447032 Rat 1358904 Cm39 Cardiac mass QTL 39 2.26 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 1354617 Bp240 Blood pressure QTL 240 4 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 26917817 81754745 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 182042367 Rat 1357990 Ael1 Aortic elastin QTL 1 3.1 0.00091 aorta elastin amount (VT:0003905) aortic elastin 2 19076825 64076825 Rat 1358887 Bw50 Body weight QTL 50 2.39 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1354592 Rf50 Renal function QTL 50 3.5 urine output (VT:0003620) timed urine volume (CMO:0000260) 2 53822747 74786777 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 2290453 Scl55 Serum cholesterol level QTL 55 2.83 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 2 26917817 136917119 Rat 152025206 Hrtrt23 Heart rate QTL 23 5.98 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1358894 Kidm24 Kidney mass QTL 24 4.03 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 731184 Mamtr4 Mammary tumor resistance QTL 4 0.0003 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 2 16491740 61491740 Rat 152025204 Hrtrt22 Heart rate QTL 22 5.6 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 61371 Edpm1 Estrogen-dependent pituitary mass QTL 1 4 0.05 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 35134841 88029593 Rat 1354601 Slep1 Serum leptin concentration QTL 1 5.39 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 2 43171017 184114403 Rat 1354603 Bp243 Blood pressure QTL 243 3.9 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 26917817 127469484 Rat
D2Rat385
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 2 59,250,223 - 59,250,466 (+) Marker Load Pipeline mRatBN7.2 2 57,522,996 - 57,523,239 (+) MAPPER mRatBN7.2 Rnor_6.0 2 57,633,081 - 57,633,323 NCBI Rnor6.0 Rnor_5.0 2 79,117,766 - 79,118,008 UniSTS Rnor5.0 RGSC_v3.4 2 58,035,189 - 58,035,432 RGD RGSC3.4 RGSC_v3.4 2 58,035,190 - 58,035,432 UniSTS RGSC3.4 RGSC_v3.1 2 57,963,354 - 57,963,967 RGD Celera 2 53,136,745 - 53,136,987 UniSTS SHRSP x BN Map 2 24.0998 UniSTS SHRSP x BN Map 2 24.0998 RGD Cytogenetic Map 2 q16 UniSTS
D2Got310
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 57,501,761 - 57,501,956 (+) MAPPER mRatBN7.2 Rnor_6.0 2 57,611,846 - 57,612,040 NCBI Rnor6.0 Rnor_5.0 2 79,096,531 - 79,096,725 UniSTS Rnor5.0 RGSC_v3.4 2 58,013,952 - 58,014,150 UniSTS RGSC3.4 Celera 2 53,115,573 - 53,115,767 UniSTS Cytogenetic Map 2 q16 UniSTS
RH143372
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 57,399,777 - 57,399,949 (+) MAPPER mRatBN7.2 Rnor_6.0 2 57,508,854 - 57,509,025 NCBI Rnor6.0 Rnor_5.0 2 78,993,539 - 78,993,710 UniSTS Rnor5.0 RGSC_v3.4 2 57,909,641 - 57,909,812 UniSTS RGSC3.4 Celera 2 53,014,321 - 53,014,492 UniSTS Cytogenetic Map 2 q16 UniSTS
AW532132
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 57,569,595 - 57,569,785 (+) MAPPER mRatBN7.2 Rnor_6.0 2 57,679,821 - 57,680,010 NCBI Rnor6.0 Rnor_5.0 2 79,164,506 - 79,164,695 UniSTS Rnor5.0 RGSC_v3.4 2 58,081,596 - 58,081,785 UniSTS RGSC3.4 Celera 2 53,183,313 - 53,183,502 UniSTS Cytogenetic Map 2 q16 UniSTS
BE117972
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 57,502,189 - 57,502,404 (+) MAPPER mRatBN7.2 Rnor_6.0 2 57,612,274 - 57,612,488 NCBI Rnor6.0 Rnor_5.0 2 79,096,959 - 79,097,173 UniSTS Rnor5.0 RGSC_v3.4 2 58,014,384 - 58,014,598 UniSTS RGSC3.4 Celera 2 53,116,001 - 53,116,215 UniSTS RH 3.4 Map 2 331.7 UniSTS Cytogenetic Map 2 q16 UniSTS
MARC_21845-21846:1025102921:1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 57,483,006 - 57,483,771 (+) MAPPER mRatBN7.2 Rnor_6.0 2 57,593,094 - 57,593,858 NCBI Rnor6.0 Rnor_5.0 2 79,077,779 - 79,078,543 UniSTS Rnor5.0 RGSC_v3.4 2 57,995,199 - 57,995,963 UniSTS RGSC3.4 Celera 2 53,096,825 - 53,097,589 UniSTS Cytogenetic Map 2 q16 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000083247 ⟹ ENSRNOP00000071473
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 57,399,445 - 57,565,899 (-) Ensembl Rnor_6.0 Ensembl 2 57,509,428 - 57,600,820 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000097994 ⟹ ENSRNOP00000078828
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 57,399,760 - 57,565,899 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000110737 ⟹ ENSRNOP00000093925
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 57,399,445 - 57,489,347 (-) Ensembl
RefSeq Acc Id:
NM_001427697 ⟹ NP_001414626
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 59,126,676 - 59,293,277 (-) NCBI
RefSeq Acc Id:
NM_001427698 ⟹ NP_001414627
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 59,126,676 - 59,293,277 (-) NCBI
RefSeq Acc Id:
XM_039103537 ⟹ XP_038959465
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 59,126,987 - 59,314,841 (-) NCBI mRatBN7.2 2 57,400,349 - 57,586,770 (-) NCBI
RefSeq Acc Id:
XM_039103539 ⟹ XP_038959467
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 59,126,987 - 59,292,985 (-) NCBI mRatBN7.2 2 57,400,296 - 57,565,947 (-) NCBI
RefSeq Acc Id:
XM_039103540 ⟹ XP_038959468
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 59,126,987 - 59,216,351 (-) NCBI mRatBN7.2 2 57,399,443 - 57,489,124 (-) NCBI
RefSeq Acc Id:
XM_063281521 ⟹ XP_063137591
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 59,126,987 - 59,314,628 (-) NCBI
RefSeq Acc Id:
XR_010063589
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 59,141,387 - 59,292,985 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000071473 ⟸ ENSRNOT00000083247
RefSeq Acc Id:
XP_038959468 ⟸ XM_039103540
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I6AXR8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038959467 ⟸ XM_039103539
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6AXR8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038959465 ⟸ XM_039103537
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6AXR8 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000078828 ⟸ ENSRNOT00000097994
Ensembl Acc Id:
ENSRNOP00000093925 ⟸ ENSRNOT00000110737
RefSeq Acc Id:
NP_001414626 ⟸ NM_001427697
- Peptide Label:
isoform 1
- UniProtKB:
A0A8I6AXR8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
NP_001414627 ⟸ NM_001427698
- Peptide Label:
isoform 2
- UniProtKB:
A0A8I5ZLR4 (UniProtKB/TrEMBL), A0A8I6AXR8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063137591 ⟸ XM_063281521
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6AXR8 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-04-27
Nipbl
NIPBL, cohesin loading factor
Nipbl
Nipped-B homolog (Drosophila)
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2013-05-24
Nipbl
Nipped-B homolog (Drosophila)
LOC681423
similar to delangin isoform A
Data merged from RGD:1595401
1643240 APPROVED
2010-01-27
Nipbl
Nipped-B homolog (Drosophila)
NIPBL
Nipped-B homolog (Drosophila)
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2006-11-20
LOC681423
similar to delangin isoform A
Symbol and Name status set to provisional
70820 PROVISIONAL
2006-03-30
NIPBL
Nipped-B homolog (Drosophila)
delangin
Name updated
1299863 APPROVED
2005-12-06
NIPBL
delangin
NIPBL_predicted
delangin (predicted)
Symbol and Name updated
1559027 APPROVED
2005-01-12
NIPBL_predicted
delangin (predicted)
Symbol and Name status set to approved
70820 APPROVED
